Author

Jennifer Knox

Institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre

Observed institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre

OpenAlex ID: A5152774556

A pivotal Phase 2 study of derazantinib for previously-treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 aberrations: FIDES-01

2026 · Mitesh J. Borad, Michele Droz dit Busset, et al. · Hepatology

Abstract A098: Preliminary results of the wearable devices and remote toxicity checks to predict health outcomes in pancreatic cancer (WATCH-PC) study

2026 · Emil Hodzic-Santor, Andrew CL. Lam, et al. · Cancer Research

Abstract B026: Multimodal spatial profiling uncovers cell state–associated receptor–ligand interactions in pancreatic ductal adenocarcinoma

2026 · Sibyl Drissler, Noor Shakfa, et al. · Cancer Research

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types

2026 · Catia Gaspar, Benson Wu, et al. · Frontiers in Oncology

Works count: 4

Citation count:

H-index:

I10-index: